Edición Oncoliver 
Home » Oncoliver » Edición Oncoliver » Edición de Bibliografía
| Título | Autores | Fecha de publicación | Tipo de publicación | Publicado en | |
|---|---|---|---|---|---|
| Multidisciplinary Clinical Approach to Cancer Patients with Immune-Related Adverse Events Induced by Checkpoint Inhibitors | Londoño MC, Reig M; RETOINMUNO Multidisciplinary Group. | 19/11/2020 | Revisiones | Cancers (Basel). |
|
| Assessing the impact of COVID-19 on liver cancer management (CERO-19) | Muñoz-Martínez S, Sapena V, Forner A, Nault JC, Sapisochin G, Rimassa L, Sangro B, Bruix J, Sanduzzi-Zamparelli M, Hołówko W, El Kassas M, Mocan T, Bouattour M, Merle P, Hoogwater FJH, Alqahtani SA, Reeves HL, Pinato DJ, Giorgakis E, Meyer T, Villadsen GE, Wege H, Salati M, Mínguez B, Di Costanzo GG, Roderburg C, Tacke F, Varela M, Galle PR, Alvares-da-Silva MR, Trojan J, Bridgewater J, Cabibbo G, Toso C, Lachenmayer A, Casadei-Gardini A, Toyoda H, Lüdde T, Villani R, Matilla Peña AM, Guedes Leal CR, Ronzoni M, Delgado M, Perelló C, Pascual S, Lledó JL, Argemi J, Basu B, da Fonseca L, Acevedo J, Siebenhüner AR, Braconi C, Meyers BM, Granito A, Sala M, Rodríguez Lope C, Blaise L, Romero-Gómez M, Piñero F, Gomez D, Mello V, Pinheiro Alves RC, França A, Branco F, Brandi G, Pereira G, Coll S, Guarino M, Benítez C, Anders MM, Bandi JC, Vergara M, Calvo M, Peck-Radosavljevic M, García-Juárez I, Cardinale V, Lozano M, Gambato M, Okolicsanyi S, Arraez DM, Elvevi A, Muñoz AE, Lué A, Iavarone M, Reig M | 23/02/2021 | Originales | JHEP reports |
|
| Radiological response to nivolumab in patients with hepatocellular carcinoma: A multicenter analysis of real-life practice | Rimola J, Da Fonseca LG, Sapena V, Perelló C, Guerrero A, Simó MT, Pons M, De La Torre-Aláez M, Márquez L, Calleja JL, Lledó JL, Varela M, Mínguez B, Sangro B, Matilla A, Torres F, Ayuso C, Bruix J, Reig M. | 01/02/2021 | Originales | Eur J Radiol |
|
| Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates | Zobair Younossi 1, Maria Stepanova 2, Janus P Ong 3, Ira M Jacobson 4, Elisabetta Bugianesi 5, Ajay Duseja 6, Yuichiro Eguchi 7, Vincent W Wong 8, Francesco Negro 9, Yusuf Yilmaz 10, Manuel Romero-Gomez 11, Jacob George 12, Aijaz Ahmed 13, Robert Wong 14, Issah Younossi 2, Mariam Ziayee 2, Arian Afendy 2, Global Nonalcoholic Steatohepatitis Council | 17/03/2019 | Originales | Clin Gastroenterol Hepatol . |
|
| Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy | José A Del Campo 1, Marta García-Valdecasas 2, Antonio Gil-Gómez 2, Ángela Rojas 2, Paloma Gallego 1, Javier Ampuero 2, Rocío Gallego-Durán 2, Helena Pastor 2, Lourdes Grande 1, Francisco J Padillo 3, Jordi Muntané 3, Manuel Romero-Gómez 2 | 31/01/2018 | Originales | PLoS One |
|
| Diagnostic accuracy of SCCA and SCCA-IgM for hepatocellular carcinoma: A meta-analysis | Chang-Hai Liu 1 2, Antonio Gil-Gómez 1, Javier Ampuero 1 2 3, Manuel Romero-Gómez | 22/05/2018 | Originales | Liver Int . |
|
| Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: Role of statins and metformin | Javier Ampuero 1, Manuel Romero-Gomez 1 | 25/05/2018 | Originales | World J Hepatol . |
|
| Assessing the impact of COVID-19 on liver cancer management (CERO-19) | Sergio Muñoz-Martínez, Victor Sapena, Alejandro Forner, Jean-Charles Nault, Gonzalo Sapisochin, Lorenza Rimassa, Bruno Sangro, Jordi Bruix, Marco Sanduzzi-Zamparelli, Wacław Hołówko, Mohamed El Kassas, Tudor Mocan, Mohamed Bouattour, Philippe Merle, Frederik J.H. Hoogwater, Saleh A. Alqahtani, Helen L. Reeves, David J. Pinato, Emmanouil Giorgakis, Tim Meyer, Gerda Elisabeth Villadsen, Henning Wege, Massimiliano Salati, Beatriz Mínguez, Giovan Giuseppe Di Costanzo, Christoph Roderburg, Frank Tacke, María Varela, Peter R. Galle, Mario Reis Alvares-da-Silva, Jörg Trojan, John Bridgewater, Giuseppe Cabibbo, Christian Toso, Anja Lachenmayer, Andrea Casadei-Gardini, Hidenori Toyoda, Tom Lüdde, Rosanna Villani, Ana María Matilla Peña, Cassia Regina Guedes Leal, Monica Ronzoni, Manuel Delgado, Christie Perelló, Sonia Pascual, José Luis Lledó, Josepmaria Argemi, Bristi Basu, Leonardo da Fonseca, Juan Acevedo, Alexander R. Siebenhüner, Chiara Braconi, Brandon M. Meyers, Alessandro Granito, Margarita Sala, Carlos Rodríguez Lope, Lorraine Blaise, Manuel Romero-Gómez, Federico Piñero, Dhanny Gomez, Vivianne Mello, Rogerio Camargo Pinheiro Alves, Alex França, Fernanda Branco, Giovanni Brandi, Gustavo Pereira, Susanna Coll, Maria Guarino, Carlos Benítez, Maria Margarita Anders, Juan C. Bandi, Mercedes Vergara, Mariona Calvo, Markus Peck-Radosavljevic, Ignacio García-Juárez, Vincenzo Cardinale, Mar Lozano, Martina Gambato, Stefano Okolicsanyi, Dalia Morales Arraez, Alessandra Elvevi, Alberto E. Muñoz, Alberto Lué, Massimo Iavarone, Maria Reig | 23/02/2021 | Originales | JHEP Rep |
|
| Splicing factor SF3B1 is overexpressed and implicated in the aggressiveness and survival of hepatocellular carcinoma | Juan L López-Cánovas, Mercedes Del Rio-Moreno, Helena García-Fernandez, Juan M Jiménez-Vacas, M Trinidad Moreno-Montilla, Marina E Sánchez-Frias, Víctor Amado, Fernando L-López, Marcos F Fondevila, Rubén Ciria, Irene Gómez-Luque, Javier Briceño, Rubén Nogueiras, Manuel de la Mata, Justo P Castaño, Manuel Rodriguez-Perálvarez, Raúl M Luque, Manuel D Gahete | 01/01/2021 | Originales | Cancer letters |
|
| Diagnosis and treatment of hepatocellular carcinoma. Update of the consensus document of the AEEH, AEC, SEOM, SERAM, SERVEI, and SETH | María Reig, Alejandro Forner, Matías A Ávila, Carmen Ayuso, Beatriz Mínguez, María Varela, Itxarone Bilbao, José Ignacio Bilbao, Marta Burrel, Javier Bustamante, Joana Ferrer, Miguel Ángel Gómez, Josep María Llovet, Manuel De la Mata, Ana Matilla, Fernando Pardo, Miguel A Pastrana, Manuel Rodríguez-Perálvarez, Josep Tabernero, José Urbano, Ruth Vera, Bruno Sangro, Jordi Bruix | 01/01/2021 | Guías de Práctica Clínica | Medicina Clínica |
|
| ARMCX3 Mediates Susceptibility to Hepatic Tumorigenesis Promoted by Dietary Lipotoxicity. | Mirra S, Gavaldà-Navarro A, Manso Y, Higuera M, Serrat R, Salcedo MT, Burgaya F, Balibrea JM, Santamaría E, Uriarte I, Berasain C, Avila MA, Mínguez B, Soriano E, Villarroya F. | 01/03/2021 | Originales | Cancers |
|
| Assessing the impact of COVID-19 on liver cancer management (CERO-19). | Muñoz-Martínez S, Sapena V, Forner A, Nault JC, Sapisochin G, Rimassa L, Sangro B, Bruix J, Sanduzzi-Zamparelli M, Hołówko W, El Kassas M, Mocan T, Bouattour M, Merle P, Hoogwater FJH, Alqahtani SA, Reeves HL, Pinato DJ, Giorgakis E, Meyer T, Villadsen GE, Wege H, Salati M, Mínguez B, Di Costanzo GG, Roderburg C, Tacke F, Varela M, Galle PR, Alvares-da-Silva MR, Trojan J, Bridgewater J, Cabibbo G, Toso C, Lachenmayer A, Casadei-Gardini A, Toyoda H, Lüdde T, Villani R, Matilla Peña AM, Guedes Leal CR, Ronzoni M, Delgado M, Perelló C, Pascual S, Lledó JL, Argemi J, Basu B, da Fonseca L, Acevedo J, Siebenhüner AR, Braconi C, Meyers BM, Granito A, Sala M, Rodríguez-Lope C, Blaise L, Romero-Gómez M, Piñero F, Gomez D, Mello V, Pinheiro Alves RC, França A, Branco F, Brandi G, Pereira G, Coll S, Guarino M, Benítez C, Anders MM, Bandi JC, Vergara M, Calvo M, Peck-Radosavljevic M, García-Juárez I, Cardinale V, Lozano M, Gambato M, Okolicsanyi S, Morales-Arraez D, Elvevi A, Muñoz AE, Lué A, Iavarone M, Reig M. | 01/05/2021 | Originales | JHEP Rep |
|
| Diagnosis and treatment of hepatocellular carcinoma. Update of the consensus document of the AEEH, AEC, SEOM, SERAM, SERVEI, and SETH | Reig M, Forner A, Ávila MA, Ayuso C, Mínguez B, Varela M, Bilbao I, Bilbao JI, Burrel M, Bustamante J, Ferrer J, Gómez MÁ, Llovet JM, De la Mata M, Matilla A, Pardo F, Pastrana MA, Rodríguez-Perálvarez M, Tabernero J, Urbano J, Vera R, Sangro B, Bruix J. | 01/05/2021 | Guías de Práctica Clínica | Medicina Clínica |
|
| Radiological response to nivolumab in patients with hepatocellular carcinoma: A multicenter analysis of real-life practice | Rimola J, Da Fonseca LG, Sapena V, Perelló C, Guerrero A, Simó MT, Pons M, De La Torre-Aláez M, Márquez L, Calleja JL, Lledó JL, Varela M, Mínguez B, Sangro B, Matilla A, Torres F, Ayuso C, Bruix J, Reig M. | 01/02/2021 | Originales | Eur J Radiol. |
|
| Molecular characterization of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis | Roser Pinyol, Sara Torrecilla, Huan Wang, Carla Montironi, Marta Piqué-Gili, Miguel Torres-Martin, Leow Wei-Qiang, Catherine Elizabeth Willoughby, Pierluigi Ramadori, Carmen Andreu-Oller, Patricia Taik, Youngmin Lee, Agrin Moeini, Judit Peix, Suzanne Faure-Dupuy, Tobias Riedl, Svenja Schuehle, Claudia Pinto Marques Souza de Oliveira, Venancio Avancini Ferreira Alves, Paolo Boffetta, Anja Lachenmayer, Stephanie Roessler, Beatriz Minguez, Peter Schirmacher, Jean-François Dufour, Swan Nio Thung, Helen Louise Reeves, Flair José Carrilho, Charissa Chang, Andrew Victor Uzilov, Mathias Heikenwalder, Arun Sanyal, Scott Laurence Friedman, Daniela Sia, Josep M.Llovet | 01/10/2021 | Originales | Journal of Hepatology |
|
| Thermal Ablation for Intrahepatic Cholangiocarcinoma in Cirrhosis: Safety and Efficacy in Non-Surgical Patients | Díaz-González Á, Vilana R, Bianchi L, García-Criado Á, Rimola J, Rodríguez de Lope C, Ferrer J, Ayuso C, Da Fonseca LG, Reig M, Forner A | 01/05/2020 | Originales | J Vasc Interv Radiol. 2020 May;31(5):710-719. |
|
| International and multicenter real-world study of sorafenib-treated patients with hepatocellular carcinoma under dialysis | Díaz-González Á, Sanduzzi-Zamparelli M, da Fonseca LG, Di Costanzo GG, Alves R, Iavarone M, Leal C, Sacco R, Matilla AM, Hernández-Guerra M, Aballay Soteras G, Wörns MA, Pinter M, Varela M, Ladekarl M, Chagas AL, Mínguez B, Arenas JI, Granito A, Sánchez-Torrijos Y, Rojas Á, Rodríguez de Lope C, Alvares-da-Silva MR, Pascual S, Rimassa L, Lledó JL, Huertas C, Sangro B, Giannini EG, Delgado M, Vergara M, Perelló C, Lue A, Sala M, Gallego A, Coll S, Hernáez T, Piñero F, Pereira G, França A, Marín J, Anders M, Mello V, Lozano M, Nault JC, Menéndez J, García Juárez I, Bruix J, Reig M | 01/06/2020 | Originales | Liver Int. 2020 Jun;40(6):1467-1476 |
|
| llncRNA-H19 as a marker of liver disease progression: Hepatocellular Carcinoma | Ángela Rojas1 2, Antonio Gil-Gomez1 3, Patricia de la Cruz-Ojeda4, Rocio Munoz Hernandez1 2, Yolanda Sánchez5 , Rocío Gallego-Durán1 2, M. Carmen Rico1 , Maria Teresa Ferrer5 , Raquel Millan1 , Rocío Montero-Vallejo1 , Sheila Gato Zambrano1 , Francisco Javier Padillo6 , Jordi Muntané4 , Javier Ampuero1 2 5, Manuel Romero Gomez1 2 5 | 01/02/2021 | Originales | EASL summit |
|
| P072YI Alteration of miRNA content in extracellular vesicles in Sorafenib-treated liver cancer cells. miRNA prognostic value in plasma from patients with advanced HCC treated with Sorafenib | Patricia de la Cruz-Ojeda1 2, Elena Navarro-Villarán1 3, María Isabel Gómez-Espejo4, Inés María Fernández-Luque4, Manuela Fátima Domínguez5, Víctor Sapena6, Juan Manuel Praena-Fernández7, Félix Royo8 , María Azparren-Angulo8, Francisco Javier Castell-Monsalve9, Concepción Meana5, Loreto Boix3 6, Álvaro Giráldez5, María Reig3 6, Juan Manuel Falcón-Pérez8 10, Jordi Bruix3 6, María Teresa Ferrer5 , Jordi Muntané1 2 3 4 | Originales | EASL Summit |
|
|
| Impact of HIV on the survival of hepatocellular carcinoma in hepatitis C virus-infected patients | Merchante N, Rodríguez-Fernández M, Figueruela B, Rodríguez-Arrondo F, Revollo B, Ibarra S, Téllez F, Merino E, Montero-Alonso M, Galindo MJ, Rivero-Juárez A, Santos IL, Delgado-Fernández M, García-Deltoro M, Vera-Méndez FJ, García MA, Aguirrebengoa K, Portu J, Ríos-Villegas MJ, Villalobos M, Alemán-Valls MR, Mínguez C, Galera C, Macías J, Pineda JA; GEHEP-002 Study Group. | 01/08/2020 | Originales | AIDS 2020, Vol 34 No 10 |
|
| Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma | Cabibbo G, Celsa C, Enea M, Battaglia S, Rizzo GEM, Busacca A, Matranga D, Attanasio M, Reig M, Craxì A, Cammà C. | 30/12/2020 | Originales | Cancers (Basel). |
|
| Pharmacokinetics and pharmacogenetics of sorafenib in patients with hepatocellular carcinoma: Implications for combination trials | Díaz-González Á, Sapena V, Boix L, Brunet M, Torres F, LLarch N, Samper E, Millán O, Corominas J, Iserte G, Sanduzzi-Zamparelli M, da Fonseca LG, Darnell A, Belmonte E, Forner A, Ayuso C, Bruix J, Reig M. | 01/10/2020 | Originales | Liver Int. |
|
| Tyrosine Kinase Inhibitors and Hepatocellular Carcinoma | da Fonseca LG, Reig M, Bruix J. | 01/11/2021 | Revisiones | Clin Liver Dis. |
|
| Does transient arterial-phase respiratory-motion-related artifact impact on diagnostic performance? An intra-patient comparison of extracellular gadolinium versus gadoxetic acid | Rimola J, Darnell A, Belmonte E, Sapena V, Caparroz C, Llarch N, Reig M, Forner A, Bruix J, Ayuso C. | 30/12/2020 | Originales | Eur Radiol |
|
| Hepatic epithelioid hemangioendothelioma: An international multicenter study. | Sanduzzi-Zamparelli M, Rimola J, Montironi C, Nunes V, Alves VAF, Sapena V, da Fonseca LG, Forner A, Carrilho FJ, Díaz A, Fuster C, Ferrer J, Fuster J, Ayuso C, Solé M, Bruix J, Reig M; Epithelioid Hemangioendothelioma International Network (EHIN). | 01/09/2020 | Originales | Dig Liver Dis. |
|
| From nanofiltration membrane permeances to design projections for the remediation and valorisation of acid mine waters | López J, Reig M, Vecino X, Gibert O, Cortina JL. | 10/10/2020 | Revisiones | Sci Total Environ. |
|
| International and multicenter real-world study of sorafenib-treated patients with hepatocellular carcinoma under dialysis | Díaz-González Á, Sanduzzi-Zamparelli M, da Fonseca LG, Di Costanzo GG, Alves R, Iavarone M, Leal C, Sacco R, Matilla AM, Hernández-Guerra M, Aballay Soteras G, Wörns MA, Pinter M, Varela M, Ladekarl M, Chagas AL, Mínguez B, Arenas JI, Granito A, Sánchez-Torrijos Y, Rojas Á, Rodríguez de Lope C, Alvares-da-Silva MR, Pascual S, Rimassa L, Lledó JL, Huertas C, Sangro B, Giannini EG, Delgado M, Vergara M, Perelló C, Lue A, Sala M, Gallego A, Coll S, Hernáez T, Piñero F, Pereira G, França A, Marín J, Anders M, Mello V, Lozano M, Nault JC, Menéndez J, García Juárez I, Bruix J, Reig M. | 01/06/2020 | Originales | Liver Int. |
|
| Regorafenib Alteration of the BCL-xL/MCL-1 Ratio Provides a Therapeutic Opportunity for BH3-Mimetics in Hepatocellular Carcinoma Models | Cucarull B, Tutusaus A, Subías M, Stefanovic M, Hernáez-Alsina T, Boix L, Reig M, García de Frutos P, Marí M, Colell A, Bruix J, Morales A. | 01/02/2020 | Originales | Cancers (Basel). |
|
| Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma | Sangro B, Chan SL, Meyer T, Reig M, El-Khoueiry A, Galle PR. | 01/02/2020 | Revisiones | J Hepatol |
|
| Short-term Safety and Quality of Life Outcomes Following Radioembolization in Primary and Secondary Liver Tumours: a Multi-centre Analysis of 200 Patients in France. | Loffroy R, Ronot M, Greget M, Bouvier A, Mastier C, Sengel C, Tselikas L, Arnold D, Maleux G, Pelage JP, Pellerin O, Peynircioglu B, Sangro B, Schaefer N, Urdániz M, Kaufmann N, Bilbao JI, Helmberger T, Vilgrain V; CIRT-FR Principal Investigators. | 01/01/2021 | Originales | Cardiovasc Intervent Radiol |
|
| The CIREL Cohort: A Prospective Controlled Registry Studying the Real-Life Use of Irinotecan-Loaded Chemoembolisation in Colorectal Cancer Liver Metastases: Interim Analysis. | Pereira PL, Iezzi R, Manfredi R, Carchesio F, Bánsághi Z, Brountzos E, Spiliopoulos S, Echevarria-Uraga JJ, Gonçalves B, Inchingolo R, Nardella M, Pellerin O, Sousa M, Arnold D, de Baère T, Gomez F, Helmberger T, Maleux G, Prenen H, Sangro B, Zeka B, Kaufmann N, Taieb J. | 01/01/2021 | Originales | Cardiovasc Intervent Radiol |
|
| Clinical Application of Trans-Arterial Radioembolization in Hepatic Malignancies in Europe: First Results from the Prospective Multicentre Observational Study CIRSE Registry for SIR-Spheres Therapy (CIRT) | Helmberger T, Golfieri R, Pech M, Pfammatter T, Arnold D, Cianni R, Maleux G, Munneke G, Pellerin O, Peynircioglu B, Sangro B, Schaefer N, de Jong N, Bilbao JI; On behalf of the CIRT Steering Committee; On behalf of the CIRT Principal Investigators. | 01/01/2021 | Originales | Cardiovasc Intervent Radiol |
|
| Association of inflammatory biomarkers with clinical outcomes in nivolumab- treated patients with advanced hepatocellular carcinoma. | Sangro B, Melero I, Wadhawan S, Finn RS, Abou-Alfa GK, Cheng AL, Yau T, Furuse J, Park JW, Boyd Z, Tang HT, Shen Y, Tschaika M, Neely J, El-Khoueiry A | 01/12/2020 | Originales | J Hepatol |
|
| Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma. | von Felden J, Craig AJ, Garcia-Lezana T, Labgaa I, Haber PK, D’Avola D, Asgharpour A, Dieterich D, Bonaccorso A, Torres-Martin M, Sia D, Sung MW, Tabrizian P, Schwartz M, Llovet JM, Villanueva A. | 01/01/2021 | Originales | Oncogene |
|
| Dual Pharmacological Targeting of HDACs and PDE5 Inhibits Liver Disease Progression in a Mouse Model of Biliary Inflammation and Fibrosis. | Claveria-Cabello A, Colyn L, Uriarte I, Latasa MU, Arechederra M, Herranz JM, Alvarez L, Urman JM, Martinez-Chantar ML, Banales JM, Sangro B, Rombouts K, Oyarzabal J, Marin JJG, Berasain C, Avila MA, Fernandez-Barrena MG. | 13/12/2020 | Originales | Cancers (Basel) |
|
| Radiological response to nivolumab in patients with hepatocellular carcinoma: A multicenter analysis of real-life practice. | Rimola J, Da Fonseca LG, Sapena V, Perelló C, Guerrero A, Simó MT, Pons M, De La Torre-Aláez M, Márquez L, Calleja JL, Lledó JL, Varela M, Mínguez B, Sangro B, Matilla A, Torres F, Ayuso C, Bruix J, Reig M. | 17/12/2020 | Originales | Eur J Radiol |
|
| International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres. | Levillain H, Bagni O, Deroose CM, Dieudonné A, Gnesin S, Grosser OS, Kappadath SC, Kennedy A, Kokabi N, Liu DM, Madoff DC, Mahvash A, Martinez de la Cuesta A, Ng DCE, Paprottka PM, Pettinato C, Rodríguez-Fraile M, Salem R, Sangro B, Strigari L, Sze DY, de Wit van der Veen BJ, Flamen P. | 12/01/2021 | Guías de Práctica Clínica | Eur J Nucl Med Mol Imaging. |
|
| Diagnosis and treatment of hepatocellular carcinoma. Update of the consensus document of the AEEH, AEC, SEOM, SERAM, SERVEI, and SETH. | Reig M, Forner A, Ávila MA, Ayuso C, Mínguez B, Varela M, Bilbao I, Bilbao JI, Burrel M, Bustamante J, Ferrer J, Gómez MÁ, Llovet JM, De la Mata M, MatillaA, Pardo F, Pastrana MA, Rodríguez-Perálvarez M, Tabernero J, Urbano J, Vera R, Sangro B, Bruix J. | 15/01/2021 | Guías de Práctica Clínica | Med Clin (Barc). |
|
| Splicing factor SF3B1 is overexpressed and implicated in the aggressiveness and survival of hepatocellular carcinoma | Juan L López-Cánovas, Mercedes Del Rio-Moreno, Helena García-Fernandez, Juan M Jiménez-Vacas, M Trinidad Moreno-Montilla, Marina E Sánchez-Frias, Víctor Amado, Fernando L-López, Marcos F Fondevila, Rubén Ciria, Irene Gómez-Luque, Javier Briceño, Rubén Nogueiras, Manuel de la Mata, Justo P Castaño, Manuel Rodriguez-Perálvarez, Raúl M Luque, Manuel D Gahete | 01/01/2021 | Originales | Cancer letters |
|
| Diagnosis and treatment of hepatocellular carcinoma. Update of the consensus document of the AEEH, AEC, SEOM, SERAM, SERVEI, and SETH | María Reig, Alejandro Forner, Matías A Ávila, Carmen Ayuso, Beatriz Mínguez, María Varela, Itxarone Bilbao, José Ignacio Bilbao, Marta Burrel, Javier Bustamante, Joana Ferrer, Miguel Ángel Gómez, Josep María Llovet, Manuel De la Mata, Ana Matilla, Fernando Pardo, Miguel A Pastrana, Manuel Rodríguez-Perálvarez, Josep Tabernero, José Urbano, Ruth Vera, Bruno Sangro, Jordi Bruix | 01/01/2021 | Guías de Práctica Clínica | Medicina Clínica |
|
| Is hepatitis C direct-acting antiviral therapy a risk factor for the development and recurrence of hepatocellular carcinoma? Narrative literature review and clinical practice recommendations | Delgado Martinez C, Gómez-Rubio M, Gómez-Domínguez C | 01/03/2021 | Revisiones | Ann Hepatol |
|
| Radiological response to nivolumab in patients with hepatocellular carcinoma: A multicenter analysis of real-life practice | Rimola J, Da Fonseca LG, Sapena V, Perelló C, Guerrero A, Simó MT, Pons M, De La Torre-Aláez M, Márquez L, Calleja JL, Lledó JL, Varela M, Mínguez B, Sangro B, Matilla A, Torres F, Ayuso C, Bruix J, Reig M. | 17/12/2020 | Originales | Eur J Radiol. 2020 Dec 17;135:109484. doi: 10.1016/j.ejrad.2020.109484. |
|
| Diagnosis and treatment of hepatocellular carcinoma. Update of the consensus document of the AEEH, AEC, SEOM, SERAM, SERVEI, and SETH | Reig M, Forner A, Ávila MA, Ayuso C, Mínguez B, Varela M, Bilbao I, Bilbao JI, Burrel M, Bustamante J, Ferrer J, Gómez MÁ, Llovet JM, De la Mata M, Matilla A, Pardo F, Pastrana MA, Rodríguez-Perálvarez M, Tabernero J, Urbano J, Vera R, Sangro B, Bruix J. | 15/01/2021 | Guías de Práctica Clínica | Med Clin (Barc). 2021 Jan 15:S0025-7753(20)30769-7. doi: 10.1016/j.medcli.2020.09.022. |
|
| Assessing the impact of COVID-19 on liver cancer management (CERO-19) | Sergio Muñoz-Martínez 1 , Victor Sapena 1 , Alejandro Forner 1 , Jean-Charles Nault 2 3 4 , Gonzalo Sapisochin 5 , Lorenza Rimassa 6 7 , Bruno Sangro 8 , Jordi Bruix 1 , Marco Sanduzzi-Zamparelli 1 , Wacław Hołówko 9 , Mohamed El Kassas 10 , Tudor Mocan 11 , Mohamed Bouattour 12 , Philippe Merle 13 , Frederik J H Hoogwater 14 , Saleh A Alqahtani 15 , Helen L Reeves 16 , David J Pinato 17 , Emmanouil Giorgakis 18 , Tim Meyer 19 , Gerda Elisabeth Villadsen 20 , Henning Wege 21 , Massimiliano Salati 22 , Beatriz Mínguez 23 , Giovan Giuseppe Di Costanzo 24 , Christoph Roderburg 25 , Frank Tacke 25 , María Varela 26 , Peter R Galle 27 , Mario Reis Alvares-da-Silva 28 , Jörg Trojan 29 , John Bridgewater 30 , Giuseppe Cabibbo 31 , Christian Toso 32 , Anja Lachenmayer 33 , Andrea Casadei-Gardini 34 , Hidenori Toyoda 35 , Tom Lüdde 36 , Rosanna Villani 37 , Ana María Matilla Peña 38 , Cassia Regina Guedes Leal 39 , Monica Ronzoni 40 , Manuel Delgado 41 , Christie Perelló 42 , Sonia Pascual 43 , José Luis Lledó 44 , Josepmaria Argemi 45 , Bristi Basu 46 , Leonardo da Fonseca 47 , Juan Acevedo 48 , Alexander R Siebenhüner 49 , Chiara Braconi 50 , Brandon M Meyers 51 , Alessandro Granito 52 , Margarita Sala 53 , Carlos Rodríguez Lope 54 , Lorraine Blaise 2 3 4 , Manuel Romero-Gómez 55 , Federico Piñero 56 , Dhanny Gomez 57 , Vivianne Mello 58 , Rogerio Camargo Pinheiro Alves 59 , Alex França 60 , Fernanda Branco 61 , Giovanni Brandi 62 , Gustavo Pereira 63 , Susanna Coll 64 , Maria Guarino 65 , Carlos Benítez 66 , Maria Margarita Anders 67 , Juan C Bandi 68 , Mercedes Vergara 69 70 71 , Mariona Calvo 72 , Markus Peck-Radosavljevic 73 , Ignacio García-Juárez 74 , Vincenzo Cardinale 75 , Mar Lozano 76 , Martina Gambato 77 78 , Stefano Okolicsanyi 79 , Dalia Morales Arraez 80 , Alessandra Elvevi 81 , Alberto E Muñoz 82 , Alberto Lué 83 , Massimo Iavarone 84 , Maria Reig 1 | 23/02/2021 | Originales | JHEP Rep . 2021 Feb 23;100260. doi: 10.1016/j.jhepr.2021.100260. Online ahead of print. |
|
| Evaluation of cardiovascular events in patients with hepatocellular carcinoma treated with sorafenib in the clinical practice. The CARDIO-SOR study | Carballo-Folgoso L, Álvarez-Velasco R, Lorca R, Castaño-García A, Cuevas J, González-Diéguez ML, Martín M, Álvarez-Navascués C, Cadahía V, Morís C, Rodríguez M, Varela M. | 09/05/2021 | Originales | Liver Int. 2021 Sep;41(9):2200-2211.PMID: 33966333 |
|
| Impact of Alcohol Abstinence on the Risk of Hepatocellular Carcinoma in Patients With Alcohol-Related Liver Cirrhosis | Rodríguez M, González-Diéguez ML, Varela M, Cadahía V, Andrés-Vizán SM, Mesa A, Castaño A, Alvarez-Navascués C. | 16/08/2021 | Originales | Am J Gastroenterol . 2021 Aug 16. doi: 10.14309/ajg.0000000000001399. Online ahead of print. |
|
| Assessment of the impact of COVID-19 pandemic on Liver Cancer Management (CERO-19) | Sergio Muñoz-Martínez1, Victor Sapena1, Alejandro Forner1 et al | 01/01/2021 | Originales | Journal of Hepatology reports |
|
| Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy. | Pinato DJ, Murray SM, Forner A, Kaneko T, Fessas P, Toniutto P, Mínguez B, Cacciato V, Avellini C, Diaz A, Boyton RJ, Altmann DM, Goldin RD, Akarca AU, Marafioti T, Mauri FA, Casagrande E, Grillo F, Giannini E, Bhoori S, Mazzaferro V. | 01/09/2021 | Originales | J Immunother Cancer |
|
| Durvalumab as a Successful Downstaging Therapy for Liver Transplantation in Hepatocellular Carcinoma: the Importance of a Wash-Out Period. | Sogbe M, López-Guerra D, Blanco-Fernández G, Sangro B, Narváez-Rodriguez I. | 2021 Jul | Originales | Transplantation |
|
| Advances in immunotherapy for hepatocellular carcinoma. | Sangro B, Sarobe P, Hervás-Stubbs S, Melero I. | 2021 Aug | Originales | Nat Rev Gastroenterol Hepatol. |
|
| Systemic treatment of hepatocellular carcinoma: An EASL position paper. | Bruix J, Chan SL, Galle PR, Rimassa L, Sangro B. | 2021 Oct | Guías de Práctica Clínica | J Hepatol |
|
| Liver function after combined selective internal radiation therapy or sorafenib monotherapy in advanced hepatocellular carcinoma. | Ricke J, Schinner R, Seidensticker M, Gasbarrini A, van Delden OM, Amthauer H, Peynircioglu B, Bargellini I, Iezzi R, De Toni EN, Malfertheiner P, Pech M, Sangro B. | 2021 Dec | Originales | J Hepatol |
|
Edición de Hospitales
Accediendo a edición de Hospitales podréis modificar vuestros datos recopilados a través del link «Editar».
Edición de Bibliografía
Por otro lado, en la edición de Bibliografía os aparecerá en pantalla un aviso de Acceso mediante contraseña. La contraseña será única e intercambiable y deberá solicitarla el responsable de cada hospital.